Oral Squamous Cell Carcinoma (OSCC) Recruiting Phase 2 Trials for Docetaxel (DB01248)

Back to Oral Squamous Cell Carcinoma (OSCC)

Also known as: Squamous Cell Carcinoma of the Oral Cavity / Oral Cavity Squamous Cell Carcinoma / Squamous Cell Cancer of the Oral Cavity / Squamous Cell Carcinoma (SCC) of the Oral Cavity / Oral Squamous Cell Carcinoma / Squamous Cell Carcinoma Mouth / Squamous Cell Carcinoma (SCC) of the Mouth / Squamous Cell Carcinoma of Mouth / Squamous Cell Carcinoma of the Oral / Squamous cell carcinoma of mouth (disorder)

IndicationStatusPhase
DBCOND0087451 (Oral Squamous Cell Carcinoma (OSCC))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05611463Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma PatientsTreatment
NCT04367909A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell CarcinomaTreatment